Privium Fund Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,620
Closed -$32.2K 161
2022
Q4
$32.2K Hold
11,620
0.01% 94
2022
Q3
$34K Hold
11,620
0.01% 141
2022
Q2
$58K Buy
+11,620
New +$60.9K 0.02% 136

Other funds holding CELL

Privium Fund Management's CELL Position: Q1 2023 in Review

Privium Fund Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 11,620 shares — an estimated $32.2K sold.

Privium Fund Management first reported a position in CELL in Q2 2022 and held it in 3 quarters. The position peaked at $58K in Q2 2022. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Privium Fund Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Privium Fund Management sold 11,620 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $32.2K.
  • Privium Fund Management first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Privium Fund Management's PhenomeX Inc. Common Stock position peaked at $58K in Q2 2022.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Privium Fund Management's 13F filing for Q1 2023, filed 3 May 2023.